Screening for colorectal cancer: which test can we afford?
Lansdorp-Vogelaar
I
I
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands. i.vogelaar@erasmusmc.nl
van Ballegooijen
M
M
Kuipers
E J
EJ
D000368:Aged; D003113:Colonoscopy / Q000191:economics*; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000191:economics* / Q000401:mortality; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D017048:Health Care Costs / Q000706:statistics & numerical data; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics*; D009426:Netherlands; D009780:Occult Blood; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate